These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17352251

  • 1. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer.
    Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E, Zabel M.
    Anticancer Res; 2007; 27(1A):335-42. PubMed ID: 17352251
    [Abstract] [Full Text] [Related]

  • 2. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.
    Lera J, Lara PC, Perez S, Cabrera JL, Santana C.
    Cancer; 1998 Dec 15; 83(12):2493-501. PubMed ID: 9874454
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J, Grzebieniak Z.
    Anticancer Res; 2008 Dec 15; 28(5B):2959-65. PubMed ID: 19031940
    [Abstract] [Full Text] [Related]

  • 5. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
    Xia LP, Zeng ZY, Guo ZM, Rao HL, Zeng J, Xu GP, Zhang Q.
    Ai Zheng; 2003 Jan 15; 22(1):77-82. PubMed ID: 12561442
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E, Assimakopoulos D, Peschos D, Zissi A, Skevas A, Agnantis NJ.
    Pathol Res Pract; 1999 Jan 15; 195(12):809-14. PubMed ID: 10631715
    [Abstract] [Full Text] [Related]

  • 7. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C, Calli A, Pinar E, Oncel S, Demirtaşoğlu F.
    Kulak Burun Bogaz Ihtis Derg; 2005 Jan 15; 15(1-2):9-13. PubMed ID: 16340285
    [Abstract] [Full Text] [Related]

  • 8. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, Takano H, Funaki K, Fukuyama H, Takahashi T, Sakoda S.
    J Oral Pathol Med; 2005 Nov 15; 34(10):602-7. PubMed ID: 16202080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK, Grelewski P, Popiela A, Noga L, Rabczyñski J.
    Gynecol Oncol; 2004 Oct 15; 95(1):23-31. PubMed ID: 15385106
    [Abstract] [Full Text] [Related]

  • 12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K, Hayashi K, Kobayashi R, Ishii H, Matsubayashi J, Matsumoto T, Suzuki M.
    Oncol Rep; 2008 Apr 15; 19(4):847-52. PubMed ID: 18357366
    [Abstract] [Full Text] [Related]

  • 17. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A, Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2000 Apr 15; 51(1):31-6. PubMed ID: 10833901
    [Abstract] [Full Text] [Related]

  • 18. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S, Pinto AE, Laranjeira C, Quaresma M, Soares J.
    Pathobiology; 2007 Apr 15; 74(6):323-7. PubMed ID: 18087196
    [Abstract] [Full Text] [Related]

  • 19. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
    Werynska B, Pula B, Muszczynska-Bernhard B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P, Jankowska R.
    Anticancer Res; 2011 Sep 15; 31(9):2833-9. PubMed ID: 21868526
    [Abstract] [Full Text] [Related]

  • 20. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
    Eid H, Géczi L, Mágori A, Bodrogi I, Institoris E, Bak M.
    Anticancer Res; 1998 Sep 15; 18(4C):3059-64. PubMed ID: 9713510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.